| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1004911511 |
| P356 | DOI | 10.1038/SJ.BJC.6604145 |
| P932 | PMC publication ID | 2359677 |
| P698 | PubMed publication ID | 18182974 |
| P5875 | ResearchGate publication ID | 5667393 |
| P2093 | author name string | M C Yu | |
| M C Pike | |||
| A H Wu | |||
| C-C Tseng | |||
| P2860 | cites work | Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings | Q28264426 |
| Population-based case-control study of soyfood intake and breast cancer risk in Shanghai | Q28345382 | ||
| The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones | Q34162974 | ||
| Soy, isoflavones, and breast cancer risk in Japan | Q34534619 | ||
| Diet and breast cancer in Shanghai and Tianjin, China | Q36080995 | ||
| Flavonoids and breast cancer risk in Italy | Q36095499 | ||
| Soybean products and reduction of breast cancer risk: a case-control study in Japan. | Q36614870 | ||
| Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan | Q36641110 | ||
| Flavonoid intake and breast cancer risk: a case--control study in Greece | Q36671090 | ||
| Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study | Q38976800 | ||
| Breast cancer and dietary factors in Taiwanese women | Q40392812 | ||
| Urinary phytoestrogens and postmenopausal breast cancer risk. | Q43575808 | ||
| Dietary factors protective against breast cancer in Japanese premenopausal and postmenopausal women | Q44048867 | ||
| Recent diet and breast cancer risk: the California Teachers Study (USA). | Q44081979 | ||
| Diet and premenopausal bilateral breast cancer: a case-control study | Q44109852 | ||
| Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study | Q44834257 | ||
| Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. | Q44907750 | ||
| Dietary effects on breast-cancer risk in Singapore | Q45047583 | ||
| Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women | Q45144446 | ||
| Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. | Q45932667 | ||
| Tamoxifen, soy, and lifestyle factors in Asian American women with breast cancer | Q46076303 | ||
| A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women | Q46097762 | ||
| Tofu and risk of breast cancer in Asian-Americans | Q46260228 | ||
| Adolescent and adult soy intake and risk of breast cancer in Asian-Americans | Q46406573 | ||
| Associations between soy, diet, reproductive factors, and mammographic density in Singapore Chinese women | Q46683955 | ||
| Body size, hormone therapy and risk of breast cancer in Asian-American women | Q46692027 | ||
| Dietary phytoestrogens and breast cancer risk | Q47235173 | ||
| Intake of fruits, vegetables, and soy foods in relation to breast cancer risk in Korean women: a case-control study. | Q51708331 | ||
| Soy consumption and mortality in Hong Kong: proxy-reported case-control study of all older adult deaths in 1998. | Q51809177 | ||
| Meta-analysis of soy intake and breast cancer risk. | Q55041780 | ||
| Adolescent dietary phytoestrogen intake and breast cancer risk (Canada) | Q59150901 | ||
| Two-Week Dietary Soy Supplementation Has an Estrogenic Effect on Normal Premenopausal Breast | Q59289141 | ||
| Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast | Q73194215 | ||
| Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women | Q73881402 | ||
| Dietary flavonoid intake and breast cancer risk among women on Long Island | Q79422476 | ||
| No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study | Q79428727 | ||
| Plasma phytoestrogens and subsequent breast cancer risk | Q79475968 | ||
| Consumption of soy foods and the risk of breast cancer: findings from the Japan Collaborative Cohort (JACC) Study | Q80586679 | ||
| Food and botanical groupings and risk of breast cancer: a case-control study in Shanghai, China | Q81313945 | ||
| Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study | Q81892017 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| breast cancer | Q128581 | ||
| breast neoplasm | Q23929670 | ||
| soy food | Q28836677 | ||
| P304 | page(s) | 9-14 | |
| P577 | publication date | 2008-01-08 | |
| 2008-01-15 | |||
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Epidemiology of soy exposures and breast cancer risk | |
| P478 | volume | 98 |
| Q58741224 | A case-control study of breast cancer risk factors in 7,663 women in Malaysia |
| Q36940917 | A comparison of satiety, glycemic index, and insulinemic index of wheat-derived soft pretzels with or without soy |
| Q34125778 | A hypothesis regarding the molecular mechanism underlying dietary soy-induced effects on seizure propensity |
| Q33750181 | A vegetable-fruit-soy dietary pattern protects against breast cancer among postmenopausal Singapore Chinese women |
| Q37194483 | Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study |
| Q35107003 | Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies |
| Q90749562 | Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer |
| Q33908720 | Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women |
| Q28065998 | Botanicals and Their Bioactive Phytochemicals for Women's Health |
| Q34201805 | Breast Cancer Risk - Genes, Environment and Clinics |
| Q37608623 | Breast cancer in Mongolia: an increasingly important health policy issue. |
| Q26851902 | Breast cancer risk accumulation starts early: prevention must also |
| Q26766205 | Breast cancer survival among young women: a review of the role of modifiable lifestyle factors |
| Q38032972 | Can breast cancer patients use soyafoods to help reduce risk of CHD? |
| Q34381609 | Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. |
| Q34492996 | Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women |
| Q37595210 | Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner |
| Q28386766 | Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore |
| Q91760454 | Comparative Analysis of the Effects of 17-Beta Estradiol on Proliferation, and Apoptosis in Hepatocellular Carcinoma Hep G2 and LCL-PI 11 Cell Lines |
| Q39948038 | Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints |
| Q35862704 | Correlations of urinary phytoestrogen excretion with lifestyle factors and dietary intakes among middle-aged and elderly Chinese women |
| Q26753883 | Current Status and Future Projections of Breast Cancer in Asia |
| Q37338675 | Cytology in nipple aspirate fluid during a randomized soy food intervention among premenopausal women |
| Q64255931 | Deciphering the Molecular Mechanisms Sustaining the Estrogenic Activity of the Two Major Dietary Compounds Zearalenone and Apigenin in ER-Positive Breast Cancer Cell Lines |
| Q85835654 | Development of a food compositional database for the estimation of dietary intake of phyto-oestrogens in a group of postmenopausal women previously treated for breast cancer and validation with urinary excretion |
| Q49180518 | Development of quantitative index evaluating anticancer or carcinogenic potential of diet: the anti-cancer food scoring system 1.0. |
| Q27002456 | Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases |
| Q34542382 | Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort |
| Q43078800 | Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. |
| Q37848467 | Dietary modification for women after breast cancer treatment: a narrative review |
| Q35137553 | Dietary mushroom intake may reduce the risk of breast cancer: evidence from a meta-analysis of observational studies |
| Q37079722 | Dietary soy effects on mammary gland development during the pubertal transition in nonhuman primates |
| Q49209034 | Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors |
| Q33668304 | Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice |
| Q53392633 | Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status. |
| Q51075969 | Dose-dependent effects of isoflavone exposure during early lifetime on the rat mammary gland: Studies on estrogen sensitivity, isoflavone metabolism, and DNA methylation. |
| Q36132748 | Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density |
| Q38730773 | Early Life Exposures and Adult Cancer Risk. |
| Q43162199 | Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer |
| Q37196684 | Early life and adult exposure to isoflavones and breast cancer risk |
| Q42956884 | Effect of dietary intake of isoflavones on the estrogen and progesterone receptor status of breast cancer |
| Q43008372 | Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status |
| Q51295460 | Effects of dietary genistein on hormone-dependent rat mammary carcinogenesis induced by ethyl methanesulphonate. |
| Q36142399 | Effects of high-isoflavone soy diet vs. casein protein diet and obesity on DMBA-induced mammary tumor development |
| Q33590487 | Effects of isoflavones on breast density in pre- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials |
| Q58726869 | Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation |
| Q37106258 | Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes |
| Q39536034 | Effects of red clover extracts on breast cancer cell migration and invasion |
| Q38903724 | Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity |
| Q30859481 | Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. |
| Q36929670 | Endocrine disruptors and the breast: early life effects and later life disease |
| Q35283987 | Endogenous and exogenous hormone exposure and the risk of meningioma in men. |
| Q43959355 | Endometrial, breast and liver safety of soy isoflavones plus Lactobacillus sporogenes in post-menopausal women |
| Q35670811 | Epidemiologic studies of isoflavones & mammographic density |
| Q34127131 | Estimated intake of dietary phyto-oestrogens in Australian women and evaluation of correlates of phyto-oestrogen intake |
| Q35973424 | Estrogen receptor-beta and breast cancer: translating biology into clinical practice |
| Q37710419 | Exploring the benefits and challenges of establishing a DRI-like process for bioactives |
| Q37511143 | Factors to consider in the association between soy isoflavone intake and breast cancer risk |
| Q28581258 | Feeding soy protein isolate and treatment with estradiol have different effects on mammary gland morphology and gene expression in weanling male and female rats |
| Q82425750 | Fermented and non‐fermented soy food consumption and gastric cancer in Japanese and Korean populations: A meta‐analysis of observational studies |
| Q45666730 | Food: The omnivore's labyrinth |
| Q35082728 | Gene expression profiling of breast cancer cell lines in response to soy isoflavones using a pangenomic microarray approach |
| Q36127282 | Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women |
| Q26801271 | Genistein and cancer: current status, challenges, and future directions |
| Q34308182 | Genistein protects female nonobese diabetic mice from developing type 1 diabetes when fed a soy- and alfalfa-free diet |
| Q33861798 | Glyceollins trigger anti-proliferative effects through estradiol-dependent and independent pathways in breast cancer cells |
| Q38780897 | Glycone-rich Soy Isoflavone Extracts Promote Estrogen Receptor Positive Breast Cancer Cell Growth |
| Q44840660 | Green tea consumption and breast cancer risk in Japanese women: a case-control study |
| Q37332827 | Green tea, soy, and mammographic density in Singapore Chinese women |
| Q35073708 | High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice |
| Q91968589 | Increase of isoflavones in the aglycone form in soybeans by targeted crossings of cultivated breeding material |
| Q34152723 | Individual and combined soy isoflavones exert differential effects on metastatic cancer progression |
| Q37171383 | Inflammatory markers in a 2-year soy intervention among premenopausal women |
| Q35640499 | Influence of diet on nipple aspirate fluid production and estrogen levels |
| Q28828324 | Intake Trends of Red Meat, Alcohol, and Fruits and Vegetables as Cancer-Related Dietary Factors from 1998 to 2009 |
| Q50510105 | Intake of phytoestrogen foods and supplements among women recently diagnosed with breast cancer in Ontario, Canada. |
| Q53358182 | Interaction effects between genes involved in the AKT signaling pathway and phytoestrogens in gastric carcinogenesis: a nested case-control study from the Korean Multi-Center Cancer Cohort. |
| Q26801110 | Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter |
| Q34308323 | Is soy consumption good or bad for the breast? |
| Q46082675 | Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians |
| Q45011513 | Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice |
| Q34140151 | Isoflavones – Mechanism of Action and Impact on Breast Cancer Risk |
| Q26797296 | Lifestyle, nutrition and breast cancer: facts and presumptions for consideration |
| Q37222654 | Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies |
| Q34084662 | Long-term exposure to dietary sources of genistein induces estrogen-independence in the human breast cancer (MCF-7) xenograft model |
| Q38770659 | Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer |
| Q33747218 | Mammographic breast density and serum phytoestrogen levels |
| Q34096820 | Maternal metabolic perturbations elicited by high-fat diet promote Wnt-1-induced mammary tumor risk in adult female offspring via long-term effects on mammary and systemic phenotypes |
| Q38061846 | Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. |
| Q45237128 | Metabolic studies of four soy isoflavones in rats by HPLC-HR-MS. |
| Q60445762 | Milk intake and mammographic density in premenopausal women |
| Q41818097 | Multivariate optimization of microwave-assisted extraction of zinc and copper from soybean |
| Q28078517 | Nutrient reference value: non-communicable disease endpoints--a conference report |
| Q33719986 | Nutrigenomics and Cancer Prevention |
| Q91656664 | Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence |
| Q91893401 | Opposing effects of S-equol supplementation on metabolic and behavioral parameters in mice fed a high-fat diet |
| Q34514602 | PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation |
| Q46601560 | Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison |
| Q34033220 | Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women |
| Q35629628 | Phytoestrogenic isoflavonoids in epidemiologic and clinical research |
| Q57478270 | Polyamine Metabolism and Gene Methylation in Conjunction with One-Carbon Metabolism |
| Q44958136 | Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools |
| Q37098671 | Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study |
| Q52782551 | Pterocarpan-enriched soy leaf extract ameliorates insulin sensitivity and pancreatic β-cell proliferation in type 2 diabetic mice. |
| Q27011732 | Redefining the impact of nutrition on breast cancer incidence: is epigenetics involved? |
| Q38000980 | Regulation of the immune response by soybean isoflavones |
| Q54684671 | Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk. |
| Q37882033 | Risk factors for breast cancer: epidemiological evidence from Japanese studies. |
| Q37857841 | Risks and benefits of dietary isoflavones for cancer |
| Q58577931 | Simulation with Soy Replacement Showed That Increased Soy Intake Could Contribute to Improved Nutrient Intake Profiles in the U.S. Population |
| Q40441026 | Soy Food Intake and Biomarkers of Breast Cancer Risk: Possible Difference in Asian Women? |
| Q34477740 | Soy and breast cancer: focus on angiogenesis |
| Q30435523 | Soy consumption and histopathologic markers in breast tissue using tissue microarrays |
| Q36030436 | Soy food intake after diagnosis of breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women |
| Q24609611 | Soy food intake and breast cancer survival |
| Q37284545 | Soy food supplementation, dietary fat reduction and peripheral blood gene expression in postmenopausal women--a randomized, controlled trial |
| Q36573832 | Soy foods and urinary isoprostanes: results from a randomized study in premenopausal women |
| Q36755209 | Soy intake and breast cancer risk in Singapore Chinese Health Study |
| Q38181041 | Soy intake and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population |
| Q37382228 | Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women |
| Q44120637 | Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. |
| Q35335557 | Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk |
| Q58322018 | Soy isoflavones and their relationship with microflora: beneficial effects on human health in equol producers |
| Q34152200 | Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies |
| Q36744585 | Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary |
| Q34658148 | Soy, red clover, and isoflavones and breast cancer: a systematic review |
| Q30835235 | Soy-Based Therapeutic Baby Formulas: Testable Hypotheses Regarding the Pros and Cons |
| Q60313078 | Suppression of lymphoma growth by the xenoestrogens bisphenol A and genistein |
| Q46230634 | The Effect of Reduced Dietary Fat and Soy Supplementation on Circulating Adipocytokines in Postmenopausal Women: A Randomized Controlled 2-Month Trial |
| Q44743284 | The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study |
| Q37292325 | The effects of soy consumption before diagnosis on breast cancer survival: the Multiethnic Cohort Study |
| Q36754900 | The effects of soy supplementation on gene expression in breast cancer: a randomized placebo-controlled study |
| Q35955534 | The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism |
| Q36598699 | The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy |
| Q33676455 | The potential health effects of dietary phytoestrogens |
| Q28387746 | The pros and cons of phytoestrogens |
| Q27021254 | The role of anthropometric and nutritional factors on breast cancer risk in African-American women |
| Q36667411 | The role of early life genistein exposures in modifying breast cancer risk |
| Q34247970 | The role of soy in vegetarian diets |
| Q34667497 | The volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women. |
| Q36915220 | Time course of risk factors in cancer etiology and progression |
| Q92471928 | Tofu intake is inversely associated with risk of breast cancer: A meta-analysis of observational studies |
| Q35757352 | Urinary estrogen metabolites during a randomized soy trial. |
| Q36218656 | Urinary estrogen metabolites in two soy trials with premenopausal women |
| Q34488897 | Urinary isoflavonoid excretion as a biomarker of dietary soy intake during two randomized soy trials |
| Q34060204 | Urinary phytoestrogen excretion and postmenopausal breast cancer risk: the multiethnic cohort study |
| Q56672310 | Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk |
| Q37271520 | Various doses of soy isoflavones do not modify mammographic density in postmenopausal women |
| Q37803483 | Whole versus the piecemeal approach to evaluating soy |
Search more.